Therapeutic microRNA strategies in human cancer.
MicroRNAs (miRNAs) are approximately 22 nucleotide long, noncoding, endogenous RNA molecules which exert their functions by base pairing with messenger RNAs (mRNAs), thereby regulate protein-coding gene expression. In eukaryotic cells, miRNAs play important roles in regulating biological processes such as proliferation, differentiation, apoptosis, and stem cell self-renewal. The human genome may contain as many as 1,000 miRNAs, and more than 700 of them have been identified. miRNAs are predicted to target up to one third of mRNAs. Each miRNA can target hundreds of transcripts directly or indirectly, while more than one miRNA can converge on a single transcript target. Therefore, the potential regulatory circuitry afforded by miRNA is enormous. Recently, mounting evidence implicates miRNAs as a new class of modulator for human tumor initiation and progression. Therefore, it has been proposed that manipulating miRNA activity and miRNA biogenesis may be a novel avenue for developing efficient therapies against cancer.
Li
Chunsheng
C
Center for Research on Early Detection and Cure of Ovarian Cancer, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Feng
Yi
Y
Coukos
George
G
Zhang
Lin
L
D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D020868:Gene Silencing; D018390:Gene Targeting; D016147:Genes, Tumor Suppressor / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D035683:MicroRNAs / Q000008:administration & dosage / Q000096:biosynthesis / Q000502:physiology / Q000627:therapeutic use*; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D014411:Neoplastic Stem Cells; D009857:Oncogenes / Q000235:genetics; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000627:therapeutic use
D035683:MicroRNAs; D034741:RNA, Small Interfering